# Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants

> **NCT00444457** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 1712 (actual)

## Conditions studied

- Vaccines, Pneumococcal

## Interventions

- **BIOLOGICAL:** 13-valent Pneumococcal Conjugate Vaccine
- **BIOLOGICAL:** 7vPnC

## Key facts

- **NCT ID:** NCT00444457
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 1712 (ACTUAL)
- **Last updated:** 2012-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00444457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00444457, "Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00444457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*